John Alexander Kelly - 07 Jun 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Financial Officer
Signature
/s/ Dario Scimeca, Attorney-in-fact for John Alexander Kelly
Issuer symbol
DTIL
Transactions as of
07 Jun 2024
Net transactions value
$0
Form type
4
Filing time
11 Jun 2024, 17:13:07 UTC
Previous filing
08 May 2024
Next filing
23 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +454 +1.5% 31,468 07 Jun 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -454 -100% $0.000000* 0 07 Jun 2024 Common Stock 454 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024.
F2 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3 On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024.